Isosceles News

Investing in life science companies is challenging as the pace of progression in life science and biotech innovation is progressing exponentially, with exciting breakthrough products and technologies revolutionising the diagnosis, management, and treatment of diseases. However, even the very innovative companies in this space must work hard to attract investment and, despite the significant sums of capital that flow into the sector, there are many segments of the market that … Continue reading →

We were delighted to welcome Charles O’Riordan, Investment Manager of private equity investment firm Foresight Group and Jocelyn Morgan, former Director of Finance at Clubhouse Golf, to our recent iFD Community event. Isosceles Founder and former CEO, Mike O’Connell hosted this virtual ‘on the sofa’ event and asked Charles and Jocelyn to share their perspectives of their recent PE investment journey. Related article | Flags for investment – is your … Continue reading →